<SEC-DOCUMENT>0000903423-19-000287-index.html : 20190715
<SEC-HEADER>0000903423-19-000287.hdr.sgml : 20190715
<ACCEPTANCE-DATETIME>20190715092244
ACCESSION NUMBER:		0000903423-19-000287
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20190712
DATE AS OF CHANGE:		20190715

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Axovant Gene Therapies Ltd.
		CENTRAL INDEX KEY:			0001636050
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981333697
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-88883
		FILM NUMBER:		19954225

	BUSINESS ADDRESS:	
		STREET 1:		11-12 ST. JAMES'S SQUARE
		STREET 2:		SUITE 1, 3RD FLOOR
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1Y 4LB
		BUSINESS PHONE:		44 203 318 9708

	MAIL ADDRESS:	
		STREET 1:		11 TIMES SQUARE
		STREET 2:		33RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Axovant Sciences Ltd.
		DATE OF NAME CHANGE:	20150324

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Axovant Sciences, Inc.
		DATE OF NAME CHANGE:	20150324

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Roivant Neurosciences Ltd.
		DATE OF NAME CHANGE:	20150309

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VIKING GLOBAL INVESTORS LP
		CENTRAL INDEX KEY:			0001103804
		IRS NUMBER:				134055118
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		55 RAILROAD AVENUE
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
		BUSINESS PHONE:		212-672-7050

	MAIL ADDRESS:	
		STREET 1:		55 RAILROAD AVENUE
		CITY:			GREENWICH
		STATE:			CT
		ZIP:			06830
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>axo13da7.htm
<TEXT>
Document 1 - file: axo13da7.htm

</DOCUMENT>
</SEC-DOCUMENT>